Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Masitinib for the Treatment of Alzheimer’s Disease
Miren Ettcheto, Amanda Cano, Elena Sánchez‐López, et al.
Neurodegenerative Disease Management (2021) Vol. 11, Iss. 4, pp. 263-276
Closed Access | Times Cited: 22

Showing 22 citing articles:

Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Sujata Thakur, Rishika Dhapola, Phulen Sarma, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 1-17
Closed Access | Times Cited: 248
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Implicative role of cytokines in neuroinflammation mediated AD and associated signaling pathways: Current progress in molecular signaling and therapeutics
Sneha Kumari, Rishika Dhapola, Prajjwal Sharma, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102098-102098
Closed Access | Times Cited: 15
Mast cell deficiency improves cognition and enhances disease-associated microglia in 5XFAD mice
Chih‐Chung Lin, Fanny Hérisson, Hoang Le, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113141-113141
Open Access | Times Cited: 14
Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer
Jacob J. Adashek, Chinmayi Pandya, Nicholas J. Maragakis, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Deciphering the heterogeneity and plasticity of the tumor microenvironment in liver cancer provides insights for prognosis
Yihao Sun, Guojuan Shi, Jian Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access
Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer’s Disease—Are There Connections?
Michał Fułek, Naomi Hachiya, Martyna Gachowska, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2097-2097
Open Access
CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer’s disease
Zhengrong Zhang, Qini Gan, Jingyan Han, et al.
Journal of Cerebral Blood Flow & Metabolism (2023) Vol. 43, Iss. 7, pp. 1027-1041
Closed Access | Times Cited: 12
Current trends and updates in the treatment of Alzheimer's disease
Nisha I. Parikh, Palak K. Parikh, Hetansh J. Rao, et al.
Elsevier eBooks (2024), pp. 373-390
Closed Access | Times Cited: 3
Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer’s Disease
Ahalya Muraleedharan, Swapan K. Ray
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 96-96
Open Access | Times Cited: 3
Advancements in Pharmacological Treatment of Alzheimer’s Disease: The Advent of Disease-Modifying Therapies (DMTs)
Qiong Wang, Sihui Chen, Junhui Wang, et al.
Brain Sciences (2024) Vol. 14, Iss. 10, pp. 990-990
Open Access | Times Cited: 3
Shared pathophysiology: Understanding stroke and Alzheimer’s disease
Sai Sriram, Yusuf Mehkri, Stephan Quintin, et al.
Clinical Neurology and Neurosurgery (2022) Vol. 218, pp. 107306-107306
Closed Access | Times Cited: 14
ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer’s disease
Madia Lozupone, Giuseppe Berardino, Anita Mollica, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 8, pp. 759-771
Closed Access | Times Cited: 13
The vascular contribution of apolipoprotein E to Alzheimer's disease
Feng Chen, Jing Zhao, Fanxia Meng, et al.
Brain (2024) Vol. 147, Iss. 9, pp. 2946-2965
Closed Access | Times Cited: 2
Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease
Ibtisam Mumtaz, Mir Owais Ayaz, Mohamad Sultan Khan, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 11
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches
Siva Prasad Panda, Yogita Dhurandhar, Mehak Agrawal
Mitochondrion (2022) Vol. 66, pp. 27-37
Closed Access | Times Cited: 10
Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence
Abdullah Ashraf Hamad, Basma Ehab Amer, Yousef Hawas, et al.
Neurological Sciences (2023) Vol. 45, Iss. 5, pp. 1861-1873
Open Access | Times Cited: 4
Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease
Zahra Farajzadeh Vahid, Morteza Eskandani, Hamed Dadashi, et al.
Heliyon (2024) Vol. 10, Iss. 23, pp. e40756-e40756
Open Access | Times Cited: 1
Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
Xing Fan, Liye Xia, Zheng Zhou, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 4
Interaction of Masitinib with Organic Cation Transporters
Saliha Harrach, Jasmin Haag, Martin Steinbüchel, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14189-14189
Open Access | Times Cited: 4
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Page 1

Scroll to top